Survivorship

October 9, 2023

Now Enrolling: The EAQ211 trial is evaluating the impact of social and genetic factors on outcomes in teen and young adult cancer survivors

Through a series of simple blood tests and patient questionnaires, researchers are studying the effects of trauma and other adverse life experiences on young cancer survivors
October 2, 2020

Trial Results: For women with breast cancer in the TAILORx trial, cognitive decline from chemo was early and abrupt but did not get worse over time. Cognition also declined in the group on hormone therapy alone.

Cognitive loss—or ‘brain fog’—involves memory problems, a lack of mental clarity, and difficulty keeping one’s focus. Cancer-related brain fog is common during treatment. This study dispels the idea that it is only from chemotherapy.